Chronic kidney disease, SPECT, and coronary angiography: “head of gold and feet of clay?”

Williams, Kim A.

doi:10.1007/s12350-009-9081-1

Cited by 2 publications

(1 citation statement)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although invasive coronary angiography remains the “gold standard” for many clinicians, functional imaging with measurement of parameters that quantitate coronary blood flow at rest and/or stress, or coronary flow reserve (CFR), has been shown to be superior to anatomic imaging alone [87] . This anatomic mode of assessing the impact of CAD remains despite the longstanding literature consistently indicating its limitations.…”

Section: Introductionmentioning

confidence: 99%

Cardiac CT angiography in current practice: An American society for preventive cardiology clinical practice statement✰

Budoff

Lakshmanan

Tóth

et al. 2022

American Journal of Preventive Cardiology

Self Cite

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Cardiac CT angiography in current practice: An American society for preventive cardiology clinical practice statement✰

Budoff

Lakshmanan

Tóth

et al. 2022

American Journal of Preventive Cardiology

Self Cite

View full text Add to dashboard Cite

Impact of renal dysfunction on the choice of diagnostic imaging, treatment strategy, and outcomes in patients with stable angina

Kato

Uemura

Naya

et al. 2019

Sci Rep

View full text Add to dashboard Cite

We investigated the interaction between the prognostic impact of a decrease in eGFR and the choice of initial diagnostic imaging modality for coronary artery disease. Out of 2878 patients who enrolled in the J-COMPASS study, 2780 patients underwent single photon emission computed tomography (SPECT), coronary computed tomography (CT) angiography, or coronary angiography (CAG) as an initial diagnostic test. After excluding patients with routine hemodialysis or lacked serum creatinine levels, 2096 patients in the non-decreased eGFR group (eGFR ≥ 60 ml/min/1.73 m 2 ) and 557 patients in the decreased eGFR group (eGFR < 60 ml/min/1.73 m 2 ) were analyzed in this study. Major adverse cardiac events, including death, myocardial infarction, heart failure hospitalization, and late revascularization, were followed, with a median follow-up duration of 472 days. SPECT or CAG was preferable to CT in patients in the decreased eGFR group (p < 0.0001 and p = 0.0024, respectively). There was a marginally significant interaction between the prognostic impact of a decrease in eGFR and the choice of diagnostic imaging modality (interaction-p = 0.056). A decrease in eGFR was not associated with a poor outcome in patients who underwent CT, while a decrease in eGFR was associated with poor outcomes in patients who underwent SPECT or CAG. In conclusion, the prognostic impact of a decrease in eGFR tended to be different among the initial imaging modalities.

show abstract

Chronic kidney disease, SPECT, and coronary angiography: “head of gold and feet of clay?”

Cited by 2 publications

References 18 publications

Cardiac CT angiography in current practice: An American society for preventive cardiology clinical practice statement✰

Cardiac CT angiography in current practice: An American society for preventive cardiology clinical practice statement✰

Impact of renal dysfunction on the choice of diagnostic imaging, treatment strategy, and outcomes in patients with stable angina

Contact Info

Product

Resources

About